We’re investing in improving every component – processes, scalability, raw material supplies, COGs and more – that distinguish between “what could be” and “what should be.”
The end result will be an all-modality manufacturing business for non-viral nucleic acid delivery. That means you’ll come to rely on us for:
As your team partners with us, you’ll tap into rare expertise in biomanufacturing and the inherent benefits that come with being part of truly groundbreaking initiatives. We are on a path to provide you with access to novel process tools and technologies, full supply chain integration and raw material sourcing, and digital dashboards that deliver real-time cGMP batch transparency.
